Brian Yu1, Shane Rui Zhao1, Christopher D Yan1, Mao Zhang1, Joseph C Wu2,3,4,5. 1. Stanford Cardiovascular Institute, Stanford University, Stanford, CA, 94503, USA. 2. Stanford Cardiovascular Institute, Stanford University, Stanford, CA, 94503, USA. joewu@stanford.edu. 3. Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, USA. joewu@stanford.edu. 4. Department of Radiology, Stanford University, Stanford, CA, USA. joewu@stanford.edu. 5. , 265 Campus Drive G1120B, Stanford, CA, 94305, USA. joewu@stanford.edu.
Abstract
PURPOSE OF REVIEW: Induced pluripotent stem cells (iPSCs) have become widely adopted tools in cardiovascular biology due to their ability to differentiate into patient-specific cell types. Here, we describe the current protocols, important discoveries, and experimental limitations from the iPSC-derived cell types of the human heart: cardiomyocytes, cardiac fibroblasts, vascular smooth muscle cells, endothelial cells, and pericytes. In addition, we also examine the progress of 3D-based cell culture systems. RECENT FINDINGS: There has been rapid advancement in methods to generate cardiac iPSC-derived cell types. These advancements have led to improved cardiovascular disease modeling, elucidation of interactions among different cell types, and the creation of 3D-based cell culture systems able to provide more physiologically relevant insights into cardiovascular diseases. iPSCs have become an instrumental model system in the toolbox of cardiovascular biologists. Ongoing research continues to advance the use of iPSCs in (1) disease modeling, (2) drug screening, and (3) clinical trials in a dish.
PURPOSE OF REVIEW: Induced pluripotent stem cells (iPSCs) have become widely adopted tools in cardiovascular biology due to their ability to differentiate into patient-specific cell types. Here, we describe the current protocols, important discoveries, and experimental limitations from the iPSC-derived cell types of the human heart: cardiomyocytes, cardiac fibroblasts, vascular smooth muscle cells, endothelial cells, and pericytes. In addition, we also examine the progress of 3D-based cell culture systems. RECENT FINDINGS: There has been rapid advancement in methods to generate cardiac iPSC-derived cell types. These advancements have led to improved cardiovascular disease modeling, elucidation of interactions among different cell types, and the creation of 3D-based cell culture systems able to provide more physiologically relevant insights into cardiovascular diseases. iPSCs have become an instrumental model system in the toolbox of cardiovascular biologists. Ongoing research continues to advance the use of iPSCs in (1) disease modeling, (2) drug screening, and (3) clinical trials in a dish.
Authors: Kiran Musunuru; Farah Sheikh; Rajat M Gupta; Steven R Houser; Kevin O Maher; David J Milan; Andre Terzic; Joseph C Wu Journal: Circ Genom Precis Med Date: 2018-01-12
Authors: Mitsutoshi Yamada; Bjarki Johannesson; Ido Sagi; Lisa Cole Burnett; Daniel H Kort; Robert W Prosser; Daniel Paull; Michael W Nestor; Matthew Freeby; Ellen Greenberg; Robin S Goland; Rudolph L Leibel; Susan L Solomon; Nissim Benvenisty; Mark V Sauer; Dieter Egli Journal: Nature Date: 2014-04-28 Impact factor: 49.962
Authors: J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones Journal: Science Date: 1998-11-06 Impact factor: 47.728
Authors: Guokai Chen; Daniel R Gulbranson; Zhonggang Hou; Jennifer M Bolin; Victor Ruotti; Mitchell D Probasco; Kimberly Smuga-Otto; Sara E Howden; Nicole R Diol; Nicholas E Propson; Ryan Wagner; Garrett O Lee; Jessica Antosiewicz-Bourget; Joyce M C Teng; James A Thomson Journal: Nat Methods Date: 2011-04-10 Impact factor: 28.547
Authors: K Kim; A Doi; B Wen; K Ng; R Zhao; P Cahan; J Kim; M J Aryee; H Ji; L I R Ehrlich; A Yabuuchi; A Takeuchi; K C Cunniff; H Hongguang; S McKinney-Freeman; O Naveiras; T J Yoon; R A Irizarry; N Jung; J Seita; J Hanna; P Murakami; R Jaenisch; R Weissleder; S H Orkin; I L Weissman; A P Feinberg; G Q Daley Journal: Nature Date: 2010-09-16 Impact factor: 49.962
Authors: Jiho Choi; Soohyun Lee; William Mallard; Kendell Clement; Guidantonio Malagoli Tagliazucchi; Hotae Lim; In Young Choi; Francesco Ferrari; Alexander M Tsankov; Ramona Pop; Gabsang Lee; John L Rinn; Alexander Meissner; Peter J Park; Konrad Hochedlinger Journal: Nat Biotechnol Date: 2015-10-26 Impact factor: 54.908
Authors: Monika Litviňuková; Carlos Talavera-López; Henrike Maatz; Daniel Reichart; Catherine L Worth; Eric L Lindberg; Masatoshi Kanda; Krzysztof Polanski; Matthias Heinig; Michael Lee; Emily R Nadelmann; Kenny Roberts; Liz Tuck; Eirini S Fasouli; Daniel M DeLaughter; Barbara McDonough; Hiroko Wakimoto; Joshua M Gorham; Sara Samari; Krishnaa T Mahbubani; Kourosh Saeb-Parsy; Giannino Patone; Joseph J Boyle; Hongbo Zhang; Hao Zhang; Anissa Viveiros; Gavin Y Oudit; Omer Ali Bayraktar; J G Seidman; Christine E Seidman; Michela Noseda; Norbert Hubner; Sarah A Teichmann Journal: Nature Date: 2020-09-24 Impact factor: 49.962